Company profile: Vascular Dynamics
1.1 - Company Overview
Company description
- Provider of the MobiusHD endovascular implant and catheter-based EVBA procedure to modulate the baroreflex via carotid sinus placement, aiming to correct inflexible arterial motion to treat hypertension and restore autonomic balance in heart failure patients; also conducts clinical research evaluating the safety and effectiveness of MobiusHD.
Products and services
- Clinical Research on MobiusHD: Clinical-trial-based research assessing safety and effectiveness of the MobiusHD device in heart failure patients through clinical trials
- EVBA Procedure: Catheter-based therapy performing precise placement of the MobiusHD implant in the carotid sinus to treat heart failure
- MobiusHD Device: Endovascular stent-like implant engineered to modulate the body's baroreflex mechanism, aiming to restore autonomic balance in heart failure and treat hypertension by correcting inflexible arterial motion
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vascular Dynamics
MGC Diagnostics
HQ: United States
Website
- Description: Provider of non-invasive diagnostic systems for detecting and managing cardiorespiratory disease, delivered by a global medical technology company dedicated to cardiorespiratory health solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MGC Diagnostics company profile →
LeMaitre
HQ: United States
Website
- Description: Provider of medical devices and implants for the treatment of peripheral vascular diseases, including RestoreFlow, a tissue processing division supplying human tissue allografts for peripheral vascular and cardiac disease, and the LeMaitre Valvulotome, a device that cuts valves in peripheral veins without direct vision for lower extremity arterial disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LeMaitre company profile →
NeoChord
HQ: United States
Website
- Description: Provider of devices and services for mitral valve repair on a beating heart, including the NeoChord DS1000 System for echo-guided restoration of damaged mitral valve chords through a small incision; NeoChord ConsultConnect and ConnectCARD consultation services for delivery of artificial chordae tendineae to aid treatment of mitral insufficiency; and the Transcatheter Transseptal NeoChord NeXuS for MRI safety under specific conditions post-treatment with NeoChord devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeoChord company profile →
Gemphire Therapeutics
HQ: United States
Website
- Description: Provider of Gemcabene, an LDL cholesterol-lowering medication, which it manufactures and markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gemphire Therapeutics company profile →
FlowMedica
HQ: United States
Website
- Description: Provider of intravascular systems for implementing targeted renal therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FlowMedica company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vascular Dynamics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vascular Dynamics
2.2 - Growth funds investing in similar companies to Vascular Dynamics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vascular Dynamics
4.2 - Public trading comparable groups for Vascular Dynamics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →